Evidence map›Paper›PMID 28115923›Full record

ArticlePPAR research2016

Peroxisome Proliferator-Activated Receptor

G Chinetti-Gbaguidi, C Copin, B Derudas, N Marx, J Eechkoute, B Staels

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in PPAR research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Evidence for the important role of inflammation in xenotransplantation.Journal of inflammation (London, England) · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

G Chinetti-GbaguidiInserm, CHU Lille, Institut Pasteur de Lille, U1011, EGID, Université de Lille, 59000 Lille, France; CHU, CNRS, Inserm, IRCAN, Université Côte d'Azur, Nice, France.ORCID 0000-0001-8048-8138
C CopinInserm, CHU Lille, Institut Pasteur de Lille, U1011, EGID, Université de Lille, 59000 Lille, France.
B DerudasInserm, CHU Lille, Institut Pasteur de Lille, U1011, EGID, Université de Lille, 59000 Lille, France.
N MarxDepartment of Cardiology, RWTH Aachen University, Aachen, Germany.
J EechkouteInserm, CHU Lille, Institut Pasteur de Lille, U1011, EGID, Université de Lille, 59000 Lille, France.ORCID 0000-0002-7222-9264
B StaelsInserm, CHU Lille, Institut Pasteur de Lille, U1011, EGID, Université de Lille, 59000 Lille, France.ORCID 0000-0002-3784-1503
Inserm · FRCentre National de la Recherche Scientifique · FRRWTH Aachen University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tissue factor (TF) is the initiator of the blood coagulation cascade after interaction with the activated factor VII (FVIIa). Moreover, the TF/FVIIa complex also activates intracellular signalling pathways leading to the production of inflammatory cytokines. The TF/FVIIa complex is inhibited by the tissue factor pathway inhibitor-1 (TFPI-1). Peroxisome proliferator-activated receptor gamma (PPAR

Identifiers

PMID28115923
PMCPMC5223051
OpenAlexW2564127438

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.